Breast Cancer
-
Second DCIS Diagnoses May Not Be Related to Initial Lesion
DNA sequencing found that in many cases when DCIS recurred, the lesion was unrelated to the first diagnosis, raising questions about how to best treat recurrence.
by Eric Fitzsimmons
-
Forward Look
Comparing Antibody-Drug Conjugates for Metastatic Breast Cancer
Results favor Enhertu for treating metastatic breast cancer that recurs or does not respond to first-line treatment.
by Kris Conner
-
When Cancer Is in the Family
You've inherited a genetic variant linked to cancer risk. Now what?
by Stephen Ornes
-
Forward Look
There’s Time to Consider Fertility Preservation Options
Women with breast cancer who choose fertility preservation have treatment outcomes similar to women who don't undergo fertility preservation.
by Kris Conner
-
Survivor Profile
A Plan of Action
Jamil Rivers supported her husband through two serious illnesses before she was diagnosed with metastatic breast cancer. Her experiences as a Black woman undergoing treatment inspired her to tackle health inequities.
by Queen Muse
-
Forward Look
Putting Data to Work
Researchers create breast cancer prediction models tailored for Asian Americans.
by Bradley Jones
-
Drug Delays Recurrence in People With Early-Stage Breast Cancer
People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.
by Pamela Rafalow Grossman
-
Moving Away From the Maximum Tolerated Dose
The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
-
Forward Look
Going Flat
Most people who opt out of breast reconstruction are satisfied with their decision but are not always supported by their surgeons.
by Kris Conner
-
Q&A
Cancer, From the Other Side
When Liza Marshall was diagnosed with stage III breast cancer, she and her husband, oncologist John Marshall, had to chart new waters.
by Marci A. Landsmann
